Randomized trial evaluates the efficacy of PCN blockade with triamcinolone-ropivacaine for pain management in TKA, indicating a potential shift in standards.
Key Points
Significantly improves postoperative analgesia and functional outcomes compared to conventional LIA techniques.
Primary endpoints include pain intensity on the Visual Analog Scale at several time points and cumulative opioid consumption.
Dual-optimization strategy employing anatomic mapping-guided PCN blockade and a novel formulation is evaluated in this phase II trial.
May redefine periarticular infiltration standards in total knee arthroplasty, especially for opioid-sensitive patients.